Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00011180 · ClinicalTrials.gov registry record
Risk Factors for Venous Thromboembolism in the Community
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 385
- Enrollment target
NCT00011180: Completed study, sponsored by Mayo Clinic.
NCT00011180 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 385 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00011180 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 385 participants
- Enrollment target
Study Summary
To evaluate the trends in the incidence of venous thromboembolism, to determine the risk factors for venous thromboembolism in patients with medical and surgical illness, and to evaluate the efficacy of the anticoagulant therapy in reducing venous thromboembolism.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 385 participants |
| Start Date | 2001-04 |
| Est. Completion | 2009-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00011180
The ClinicalTrials.gov registry entry for NCT00011180 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 385 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00011180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00011180 about?
NCT00011180 is a clinical study titled "Risk Factors for Venous Thromboembolism in the Community". To evaluate the trends in the incidence of venous thromboembolism, to determine the risk factors for venous thromboembolism in patients with medical and surgical illness, and to evaluate the efficacy of the anticoagulant therapy in reducing venous thromboembolism.
What is the current status of trial NCT00011180?
This trial is currently completed. The enrollment target is 385 participants. The study started on 2001-04. Estimated completion is 2009-05.
Who is sponsoring clinical trial NCT00011180?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.